Cargando…
Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein
OBJECTIVE: Cholesteryl ester transfer protein (CETP) plays a central role in the metabolism of high-density lipoprotein particles. Therefore, we searched for new drugs that bind to CETP and modulate its activity. METHODS: A preliminary pharmacophore-based parallel screening approach indicated that l...
Autores principales: | Duwensee, Kristina, Schwaiger, Stefan, Tancevski, Ivan, Eller, Kathrin, van Eck, Miranda, Markt, Patrick, Linder, Tobias, Stanzl, Ursula, Ritsch, Andreas, Patsch, Josef R., Schuster, Daniela, Stuppner, Hermann, Bernhard, David, Eller, Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212649/ https://www.ncbi.nlm.nih.gov/pubmed/21820657 http://dx.doi.org/10.1016/j.atherosclerosis.2011.07.023 |
Ejemplares similares
-
Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts
por: Reisinger, Ute, et al.
Publicado: (2009) -
Leoligin, the Major Lignan from Edelweiss (Leontopodium nivale subsp. alpinum), Promotes Cholesterol Efflux from THP-1 Macrophages
por: Wang, Limei, et al.
Publicado: (2016) -
Leoligin-inspired synthetic lignans with selectivity for cell-type and bioactivity relevant for cardiovascular disease
por: Linder, Thomas, et al.
Publicado: (2019) -
Lignan formation in hairy root cultures of Edelweiss (Leontopodium nivale ssp. alpinum (Cass.) Greuter)
por: Wawrosch, Christoph, et al.
Publicado: (2014) -
Inhibition of hepatic scavenger receptor-class B type I by RNA interference decreases atherosclerosis in rabbits
por: Demetz, Egon, et al.
Publicado: (2012)